20 Jul MILESTONE FOR SAFE AND STANDARDIZED HYPERTHERMIA TREATMENT PLANNING: HYPERPLAN® SUCCESSFULLY ACHIEVES CE CERTIFICATION
HyperPlan®, the hyperthermia treatment planning software developed by Dr. Sennewald Medizintechnik GmbH, has successfully completed the certification process under the Medical Device Regulation (MDR). This marks a significant milestone in modern, software-assisted hyperthermia treatment planning and confirms that the software innovation meets the essential safety and performance requirements for medical devices as defined by Regulation (EU) 2017/745. As the first certified treatment planning software for hyperthermia, HyperPlan® strengthens confidence among both patients and healthcare professionals while ensuring the highest standards of safety and quality.
According to the National Cancer Institute, hyperthermia is a type of treatment in which body tissue is exposed to high temperatures to damage and kill cancer cells or to make cancer cells more sensitive to radiation and certain anticancer drugs — a well-established principle that HyperPlan® is now helping to deliver with greater precision and traceability than ever before.